Diagnosing Malignant Pleural Effusions with CYFRA 21-1 and CEA
Author Information
Author(s): G Salama, M Mi6dougdl, P Rouzaud, M-A Mauduyt, M-C Pujazon, C Vincent, P CarIes, G Serre
Primary Institution: University of Toulouse 111, France
Hypothesis
The study aims to evaluate the effectiveness of CYFRA 21-1 and carcinoembryonic antigen (CEA) in diagnosing malignant pleural effusions compared to cytological analysis.
Conclusion
The combination of CYFRA 21-1 and CEA significantly improves the diagnosis of malignant pleural effusions, especially when cytology is negative.
Supporting Evidence
- Both CYFRA 21-1 and CEA levels were significantly higher in malignant effusions compared to benign ones.
- 12 out of 16 malignant effusions with negative cytology were positive for CEA and/or CYFRA.
- CEA showed higher sensitivity in carcinomas, while CYFRA was more sensitive in mesotheliomas.
Takeaway
Doctors can use two tests, CYFRA 21-1 and CEA, to help figure out if fluid in the lungs is from cancer, especially when other tests don't show cancer.
Methodology
The study analyzed pleural fluid from 196 patients using enzyme immunoassays for CYFRA 21-1 and CEA, alongside cytological analysis.
Potential Biases
Potential bias in patient selection and the retrospective nature of the study.
Limitations
The study may not account for all types of malignancies and relies on the accuracy of cytological analysis.
Participant Demographics
196 patients, with 54.5% men in the malignant group, aged 25 to 85 years, median age 65 years.
Statistical Information
P-Value
p<0.04
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website